cartiheal
-
Sports Medicine
CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedures in the US West Coast
KFAR SABA, Israel, May 6, 2019 /PRNewswire/ — Scott A. Hacker, MD, a sports medicine orthopedic surgeon at Grossmont Hospital, San Diego, CA, enrolled and…
Read More » -
Sports Medicine
The 150th Patient in CartiHeal’s Pivotal Study Was Operated on in Tel Aviv, Israel
KFAR SABA, Israel, March 7, 2019 /PRNewswire/ — CartiHeal, developer of proprietary implants for treating cartilage and osteochondral defects in traumatic and osteoarthritic…
Read More » -
Sports Medicine
CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedures at Missouri Orthopaedic Institute
KFAR SABA, Israel, Feb. 5, 2019 /PRNewswire/ — Seth L. Sherman, MD, a sports medicine orthopaedic surgeon at Missouri Orthopaedic Institute, recently became one…
Read More » -
Extremities
CartiHeal Performs First Agili-C™ Implant Case at The Ohio State University
KFAR SABA, Israel and COLUMBUS, Ohio, Dec. 19, 2018 /PRNewswire/ — CartiHeal, developer of Agili-C, a proprietary implant for the treatment of joint surface lesions, announced…
Read More » -
Sports Medicine
CartiHeal Performs First Agili-C™ Implant Case on the East Coast
NEW YORK and KFAR SABA, Israel, Nov. 12, 2018 /PRNewswire/ — CartiHeal, developer of Agili-C, a proprietary implant for the treatment of joint surface lesions,…
Read More » -
Extremities
CartiHeal’s Agili-C™ Implant Promotes the Regenerative Capacity of Articular Cartilage Defects in Human Cadaveric Ex-vivo Model
KFAR SABA, Israel, Nov. 6, 2018 /PRNewswire/ — CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of joint surface lesions, announced today the…
Read More » -
Extremities
CartiHeal Performs the 100th Agili-C™ Implant Procedure in Italy in the Company’s IDE Multinational Pivotal Study
KFAR SABA, Israel and MILAN, Oct. 25, 2018 /PRNewswire/ — CartiHeal, developer of the proprietary Agili-C implant for the treatment of joint surface lesions, and…
Read More » -
Financial
Additional Strategic Funding for CartiHeal’s Ongoing AGILI-C™ IDE Clinical Study $2.5M boost by Bioventus brings latest investment round to $21M
KFAR SABA, ISRAEL and DURHAM, NC– January 31, 2018 CartiHeal, developer of the proprietary Agili-C implant for the treatment of…
Read More » -
Extremities
CartiHeal Raises $18.3 Million
KFAR SABA, Israel, May 8, 2017 /PRNewswire/ — Funds will support IDE clinical study for company’s Agili-C™ implant CartiHeal (2009)…
Read More » -
Hospitals
CartiHeal Announces FDA IDE Approval of Its Agili-C Implant for the Treatment of Joint Surface Lesions
KFAR SABA, Israel, Dec. 20, 2016 /PRNewswire/ — CartiHeal (2009) Ltd., developer of a cell-free, off-the-shelf implant for use in…
Read More » -
CartiHeal Raises $5 Million in Financing to Support Agili-CTM For Single Stage Arthroscopic Cartilage Regeneration
TEL AVIV, Israel–(BUSINESS WIRE)–CartiHeal (2009), Ltd, a privately held medical device company, focused on developing and bringing to market a…
Read More »